Projects
Learn about the projects completed as part of the Engineering Innovation in Health program. Many of these projects are still active and have gone on to continued success in entrepreneurship competitions. If you are interested in working on any of these projects, please contact us at EIHealth@uw.edu.
Type 1 Diabetes (T1D) is a lifelong illness that requires careful management of blood glucose levels and lifestyle choices. This illness especially impacts young adults, who need to learn to manage their illness while learning to take on independence and responsibility during their transition to adulthood. Beta Watch's solution addresses the need for a way for young adults recently diagnosed with Type 1 Diabetes (T1D) to help manage and monitor their symptoms to reduce the stress and burden caused by T1D. Their solution is a medical storage accessory that can be attached to a mobile phone. The Beta Watch case will safely and discretely house all the daily essentials that a T1D patient needs. This solution is paired with mobile application recommendations to raise awareness of existing tools that will help T1D patients manage their illness.
Engineering team
- Anne Garner
- Brendan Ball
- Abhay Bohra
- Honglam Van
- Victoria Eng
Clinicians & consultants
- Laura Smith, MS (Novo Nordisk)
- Hannah Sattler, MS (Novo Nordisk)
- Soyoung Kang, PhD (Mechanical Engineering)
Incorrect administration of insulin (e.g., too little, too much, or at wrong times) can result in transient and serious hypo- and hyperglycemia, wide glycemic excursions, and diabetic ketoacidosis. Special care must be taken to ensure that correct dose of insulin is administered. A report of cases in which providers asked patients to demonstrate his or her insulin injection technique identified serious flaws in insulin selfadministration. In one case, a patient was not properly using an insulin pen and so was unaware that she was not getting any insulin at all. In addition, the recommended practice of priming the pen before each injection to remove air from the needle reduces the insulin dose to be administered. There is a need to accurately confirm the dose of insulin injected, thus providing more reliable and accurate treatment.
Engineering team
- Miles Matsen
- Jamal Nurdin
- Edwin Antonio
- Shayla Payne
- Georges Simo
Clinicians & consultants
- Dave Szakelyhidi (Novo Nordisk)
- Lorena Wright (Nova Nordisk)
- Subbu Trikudantahan (Novo Nordisk)
- Savitha Subramanian (Novo Nordisk)
- Jonathan Posner, PhD (Mechanical Engineering)
The proper administration of insulin is imperative for the nearly 422 million adults worldwide that are affected by diabetes. Older populations of diabetes patients are twice as likely to suffer from vision impairment compared to younger patients, and are also more susceptible to dexterity challenges. To address the needs of diabetes patients with limited vision and/or dexterity, Load-a-Dose features an automated insulin loading mechanism, with audio and visual feedback.
Engineering team
- Beemnet Workeneh
- Elaine Vu-Phan
- Hyun-Ji (Erika) Lee
- Kalle Chastain
- Karley Benoff
Clinicians & consultants
- Kelly McGrath, MD (Family Medicine)
- Matt Davies, MS, PhD (Endocrinology)
- Eric Seibel, PhD (Mechanical Engineering)